BC
Broadfin Capital Portfolio holdings
AUM
$403M
1-Year Return
74.97%
This Quarter Return
+20.83%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$1.05B
AUM Growth
+$151M
(+17%)
Cap. Flow
-$66M
Cap. Flow
% of AUM
-6.27%
Top 10 Holdings %
Top 10 Hldgs %
51.35%
Holding
73
New
4
Increased
17
Reduced
19
Closed
6
Top Buys
| 1 |
Heron Therapeutics
HRTX
|
$27.6M |
| 2 |
Travere Therapeutics
TVTX
|
$18.1M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$13.8M |
| 4 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$12.6M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$10.7M |
Top Sells
| 1 |
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
|
$51.9M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$35.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$24.7M |
| 4 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$23.7M |
| 5 |
AngioDynamics
ANGO
|
$12.6M |
Sector Composition
| 1 | Healthcare | 89.55% |
| 2 | Financials | 0.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPNE
26
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $11.1M | 1% |
1,100,007
| – | – |
|
|
QLTI
27
DELISTED
QLT Inc
QLTI
| $10.9M | 0.97% |
5,269,831
+824,304
| +19% | +$1.7M |
|
|
CORI
28
DELISTED
Corium International, Inc.
CORI
| $10.8M | 0.97% |
1,919,721
| – | – |
|
|
AMRN
29
Amarin Corp
AMRN
$311M
| $10.7M | 0.96% |
167,952
-65,809
| -28% | -$4.2M |
|
|
ELGX
30
DELISTED
Endologix Inc
ELGX
| $10.2M | 0.92% |
80,000
-20,000
| -20% | -$2.56M |
|
|
PRTK
31
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $10.2M | 0.92% |
786,134
-17,198
| -2% | -$224K |
|
|
XENT
32
DELISTED
Intersect ENT, Inc
XENT
| $10.1M | 0.91% |
638,600
-72,000
| -10% | -$1.14M |
|
|
ZGNX
33
DELISTED
Zogenix, Inc.
ZGNX
| $10.1M | 0.9% |
882,312
| – | – |
|
|
RDHL
34
Redhill Biopharma
RDHL
$2.82M
| $9.96M | 0.89% |
717
-20
| -3% | -$278K |
|
|
MDCO
35
DELISTED
Medicines Co
MDCO
| $9.65M | 0.86% |
255,600
| – | – |
|
36
Assertio
ASRT
$77.7M
| $9.48M | 0.85% |
94,869
+13,705
| +17% | +$1.37M |
|
37
Catalyst Pharmaceutical
CPRX
$2.42B
| $8.94M | 0.8% |
8,200,000
| – | – |
|
38
DURECT Corp
DRRX
$59.3M
| $8.89M | 0.8% |
639,521
+349,521
| +121% | +$4.86M |
|
|
SBBP
39
DELISTED
Strongbridge Biopharma plc.
SBBP
| $8.65M | 0.78% |
1,656,706
| – | – |
|
|
EGLT
40
DELISTED
Egalet Corporation
EGLT
| $8.64M | 0.77% |
1,134,750
| – | – |
|
41
ADMA Biologics
ADMA
$4.04B
| $8.06M | 0.72% |
1,113,293
| – | – |
|
|
VXRT
42
DELISTED
Vaxart
VXRT
| $6.69M | 0.6% |
316,974
| – | – |
|
|
MRTX
43
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.61M | 0.59% |
1,000,000
+306,137
| +44% | +$2.02M |
|
|
ACGN
44
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $6.22M | 0.56% |
17,869
-4,909
| -22% | -$1.71M |
|
|
RPTP
45
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $5.96M | 0.53% |
664,800
-5,785,200
| -90% | -$51.9M |
|
46
SCYNEXIS
SCYX
$36.4M
| $5.72M | 0.51% |
147,727
| – | – |
|
|
CSII
47
DELISTED
Cardiovascular Systems, Inc.
CSII
| $5.47M | 0.49% |
230,532
-996,969
| -81% | -$23.7M |
|
|
NVRO
48
DELISTED
NEVRO CORP.
NVRO
| $5.28M | 0.47% |
50,555
-341,800
| -87% | -$35.7M |
|
49
Pacira BioSciences
PCRX
$1.2B
| $5.16M | 0.46% |
150,680
+57,300
| +61% | +$1.96M |
|
50
Arcturus Therapeutics
ARCT
$455M
| $5.06M | 0.45% |
292,493
+70,049
| +31% | +$1.21M |
|